Faes FarmaFRA:FFEA -0.11%90 Days Payable is 94.21 as of Dec. 2025, which is 6% below its 10-year median of 100.31. GuruFocus rates FRA:FFEA with a GF Score™ of 90/100 and a GF Value™ of €5.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 927 Drug Manufacturers companies, Faes Farma ranks better than 52.21% on this metric.
Faes Farma's average Accounts Payable for the
six
months ended in Dec. 2025 was €58.5 Mil. Faes Farma's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €113.4 Mil.
Hence, Faes Farma's Days Payable for the
six
months ended in Dec. 2025 was 94.21.
The historical rank and industry rank for Faes Farma's Days Payable or its related term are showing as below:
FRA:FFEA'
s Days Payable Range Over the Past 10 Years
Min: 85.34 Med: 100.31 Max: 110.78
Current: 92.93
During the past 13 years, Faes Farma's highest Days Payable was 110.78. The lowest was 85.34. And the median was 100.31.
FRA:FFEA's Days Payable is ranked better than 52.21% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs FRA:FFEA: 92.93
Faes Farma's Days Payable
declined
from Dec. 2024 (128.76) to Dec. 2025 (94.21).
It may suggest that Faes Farmaaccelerated paying its suppliers.
Faes Farma Days Payable Related Terms
Faes Farma Days Payable Historical Data
* Premium members only.
The historical data trend for Faes Farma's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FFEA vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Days Payable distribution charts can be found below:
* The bar in red indicates where Faes Farma's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Faes Farma's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (FRA:FFEA) has a Days Payable of 94.21 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Faes Farma and its competitors. This is near median its historical median of 100.31. Over the past decade, Faes Farma's Days Payable has ranged from 85.34 to 110.78. According to the industry distribution chart, Faes Farma ranks #443 out of 927 companies in the Drug Manufacturers industry, placing it in the top 47.8%.
Is Faes Farma's Days Payable too high?
Faes Farma's current Days Payable of 94.21 is near median its 10-year median of 100.31. Over the past 10 years, this metric has ranged from a low of 85.34 to a high of 110.78. The Drug Manufacturers industry median Days Payable is 90.38. Faes Farma's value of 94.21 is 4.2% above this industry median. Based on the distribution chart, Faes Farma ranks #443 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Faes Farma has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #443 out of 927 companies for Days Payable. This puts Faes Farma in the upper half of its industry. The industry median Days Payable is 90.38. Faes Farma's value of 94.21 is 4.2% above this benchmark. Historically, Faes Farma's own Days Payable has ranged from 85.34 to 110.78 over the past decade. While the company's 10-year median is 100.31 vs. the industry median of 90.38, Faes Farma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current Days Payable of 94.21 is 4.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current Days Payable is 94.21, which is near median its own 10-year median of 100.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.11, compared to a current price of €4.47 — trading 12.5% below its estimated fair value. The current Days Payable is 94.21, which is near median its 10-year median of 100.31 and 4.2% above the Drug Manufacturers industry median of 90.38. Faes Farma's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Days Payable is 94.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (FRA:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.47 is trading 12.5% below its estimated GF Value™ of €5.11.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for FRA:FFEA:
Days Payable: 94.21 (near median its 10-year median of 100.31)
GF Value™: €5.11 vs. price of €4.47 (12.5% below fair value)
Industry Position: 4.2% above the Drug Manufacturers median (#443 of 927)
No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
90GF Score
Get the complete analysis for FRA:FFEA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FFEA has been successfully added to your 
